Despite aggressive deleveraging efforts, the company maintains a strained capital structure with a debt-to-equity ratio of 1.61 and goodwill representing 81.6% of total equity as of 2026Q1.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 | Dec'01 | Dec'00 | Dec'99 | Dec'98 | Dec'97 | Dec'96 |
|---|
| Total Current Assets | 6.85B | 6.87B | 8.85B | 9.6B | 8.01B | 8.87B | 8.41B | 7.5B | 5.96B | 7.26B | 6.57B | 11.8B | 10.16B | 10.2B | 9.26B | 8.65B | 7.99B | 8.27B | 7.15B | 7.55B | 6.97B | 5.12B | 6.02B | 5.36B | 5.16B | 3.98B | 3.65B | 3.82B | 4.29B | 3.87B | 3.48B |
| Cash & Short-Term Investments | 2.02B | 1.97B | 1.76B | 3.08B | 1.72B | 2.95B | 3.73B | 3.33B | 1.84B | 3.39B | 2.8B | 7.36B | 2.92B | 2.73B | 3.27B | 2.9B | 2.69B | 2.79B | 2.13B | 2.54B | 2.48B | 841M | 1.11B | 925M | 1.17B | 582M | 579M | 606M | 709M | 465M | 761M |
| Cash Only | 2.02B | 1.97B | 1.76B | 3.08B | 1.72B | 2.95B | 3.73B | 3.33B | 1.84B | 3.39B | 2.8B | 2.21B | 2.92B | 2.73B | 3.27B | 2.9B | 2.69B | 2.79B | 2.13B | 2.54B | 2.48B | 841M | 1.11B | 925M | 1.17B | 582M | 579M | 606M | 709M | 465M | 761M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.15B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 1.7B | 1.93B | 1.73B | 1.77B | 2.62B | 2.71B | 2.08B | 1.9B | 1.84B | 1.79B | 1.69B | 1.73B | 1.88B | 2.91B | 2.42B | 2.42B | 2.27B | 2.3B | 1.98B | 2.03B | 1.84B | 1.77B | 2.09B | 1.91B | 1.84B | 1.62B | 1.54B | 1.65B | 1.75B | 1.74B | 1.49B |
| Days Sales Outstanding | 57.88 | 62.72 | 59.37 | 62.43 | 95.2 | 81.53 | 64.95 | 60.91 | 60.51 | 61.83 | 60.73 | 63.38 | 64.15 | 112.88 | 63.51 | 63.58 | 64.37 | 66.89 | 58.53 | 65.66 | 64.64 | 65.45 | 80.26 | 78.46 | 82.83 | 80.48 | 84.04 | 94.51 | 111.69 | 120.69 | 99.67 |
| Inventory | 2.32B | 2.23B | 2.05B | 1.92B | 2.68B | 2.45B | 1.92B | 1.65B | 1.67B | 1.48B | 1.43B | 1.6B | 1.58B | 3.5B | 2.8B | 2.63B | 2.37B | 2.56B | 2.36B | 2.33B | 2.07B | 1.93B | 2.13B | 2.1B | 1.75B | 1.34B | 1.16B | 1.12B | 1.17B | 1.21B | 883M |
| Days Inventory Outstanding | 108.33 | 103.58 | 112.27 | 112.73 | 150.25 | 120.57 | 98.69 | 91.4 | 95.97 | 88.11 | 86.32 | 100.56 | 93.78 | 243.22 | 150.41 | 140.09 | 125.7 | 154.6 | 138.59 | 148.31 | 133.68 | 122.07 | 139.31 | 155.11 | 147.64 | 124.1 | 116.19 | 126.7 | 151.26 | 171.56 | 119.5 |
| Other Current Assets | 816M | 479M | 2.95B | 2.51B | 618M | 390M | 342M | 315M | 404M | 368M | 391M | 680M | 3.68B | 504M | 344M | 295M | 323M | 226M | 251M | 261M | 231M | 260M | 297M | 140M | 125M | 82M | 371M | 445M | 673M | 458M | 351M |
| Total Non-Current Assets | 13B | 13.18B | 16.93B | 18.68B | 20.28B | 24.65B | 11.61B | 10.69B | 9.76B | 9.85B | 8.97B | 9.17B | 15.98B | 15.03B | 11.13B | 10.42B | 9.5B | 9.08B | 8.26B | 7.74B | 7.72B | 7.61B | 8.13B | 8.35B | 7.32B | 6.37B | 5.08B | 5.83B | 5.58B | 4.84B | 4.12B |
| Property, Plant & Equipment | 3.19B | 3.19B | 3.18B | 3.21B | 5.24B | 5.81B | 5.33B | 5.12B | 4.53B | 4.59B | 4.29B | 4.39B | 4.43B | 7.83B | 6.1B | 5.53B | 5.26B | 5.16B | 4.61B | 4.49B | 4.23B | 4.14B | 4.37B | 4.59B | 3.91B | 3.31B | 2.81B | 2.65B | 2.44B | 2.36B | 1.84B |
| Fixed Asset Turnover | 3.61x | 3.53x | 3.35x | 3.23x | 1.92x | 2.09x | 2.19x | 2.22x | 2.45x | 2.31x | 2.37x | 2.27x | 2.42x | 1.20x | 2.29x | 2.51x | 2.44x | 2.43x | 2.68x | 2.51x | 2.45x | 2.38x | 2.18x | 1.94x | 2.07x | 2.23x | 2.39x | 2.41x | 2.33x | 2.23x | 2.95x |
| Goodwill | 4.9B | 4.93B | 5.28B | 5.79B | 6.45B | 9.84B | 3.22B | 3.03B | 3B | 3.1B | 2.6B | 2.69B | 2.93B | 4.21B | 2.5B | 2.32B | 2.02B | 1.82B | 1.65B | 1.69B | 1.62B | 1.55B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 4.22B | 4.37B | 5.22B | 5.92B | 6.79B | 7.79B | 1.67B | 1.47B | 1.41B | 1.37B | 1.11B | 1.35B | 1.62B | 2.29B | 814M | 826M | 500M | 513M | 390M | 455M | 480M | 494M | 2.19B | 2.26B | 2.02B | 1.7B | 1.24B | 921M | 930M | 1.62B | 1.39B |
| Long-Term Investments | 343M | 103M | 109M | 136M | 247M | 195M | 135M | 76M | 44M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 692M | 596M | 2.94B | 3.36B | 1.27B | 642M | 512M | 372M | 292M | 379M | 348M | 390M | 6.46B | 657M | 560M | 632M | 586M | 491M | 472M | 418M | 453M | 1.42B | 1.56B | 1.5B | 1.39B | 1.36B | 1.04B | 2.25B | 2.2B | 855M | 887M |
| Total Assets | 19.85B | 20.05B | 25.78B | 28.28B | 28.29B | 33.52B | 20.02B | 18.19B | 15.72B | 17.11B | 15.55B | 20.96B | 26.14B | 25.22B | 20.39B | 19.07B | 17.49B | 17.35B | 15.4B | 15.29B | 14.69B | 12.73B | 14.15B | 13.71B | 12.48B | 10.34B | 8.73B | 9.64B | 9.87B | 8.71B | 7.6B |
| Asset Turnover | 0.55x | 0.56x | 0.41x | 0.37x | 0.36x | 0.36x | 0.58x | 0.62x | 0.71x | 0.62x | 0.65x | 0.48x | 0.41x | 0.37x | 0.68x | 0.73x | 0.73x | 0.72x | 0.80x | 0.74x | 0.71x | 0.77x | 0.67x | 0.65x | 0.65x | 0.71x | 0.77x | 0.66x | 0.58x | 0.60x | 0.72x |
| Asset Growth % | -70.1% | -22.21% | -8.82% | -0.04% | -15.61% | 67.45% | 10.04% | 15.73% | -8.13% | 10.07% | -25.84% | -19.8% | 3.62% | 23.71% | 6.91% | 9.06% | 0.78% | 12.65% | 0.73% | 4.14% | 15.39% | -10.04% | 3.21% | 9.85% | 20.64% | 18.44% | -9.45% | -2.32% | 13.39% | 14.63% | -19.51% |
| Total Current Liabilities | 3.69B | 2.97B | 6.51B | 6.5B | 4.75B | 4.24B | 3.33B | 3.23B | 2.81B | 2.82B | 2.74B | 5.75B | 6.04B | 5.25B | 4.76B | 4.86B | 4.04B | 4.46B | 3.63B | 3.81B | 3.61B | 4.17B | 4.29B | 3.8B | 3.85B | 3.29B | 3.37B | 2.7B | 2.83B | 2.56B | 2.44B |
| Accounts Payable | 1.09B | 999M | 968M | 881M | 1.11B | 1.25B | 1.04B | 892M | 998M | 920M | 791M | 716M | 677M | 1.1B | 766M | 795M | 745M | 807M | 829M | 920M | 878M | 3.24B | 3.92B | 3.11B | 3.04B | 708M | 1.99B | 1.8B | 2.02B | 1.96B | 442M |
| Days Payables Outstanding | 46.52 | 46.36 | 53.11 | 51.78 | 62.25 | 61.24 | 53.73 | 49.32 | 57.46 | 54.96 | 47.75 | 44.89 | 40.26 | 76.67 | 41.1 | 42.38 | 39.5 | 48.79 | 48.66 | 58.46 | 56.81 | 205.52 | 256.1 | 229.06 | 257.46 | 65.52 | 199.49 | 204.92 | 262.34 | 278.79 | 59.82 |
| Short-Term Debt | 842M | 84M | 2.75B | 2.67B | 1.4B | 511M | 406M | 541M | 4M | 3M | 3M | 2.58B | 1.7B | 1.04B | 350M | 446M | 24M | 711M | 394M | 425M | 234M | 924M | 361M | 153M | 220M | 201M | 634M | 255M | 271M | 144M | 346M |
| Deferred Revenue (Current) | 141M | 141M | 131M | 128M | 154M | 162M | 32M | 0 | 0 | 0 | 0 | 0 | 9M | 760M | 878M | 738M | 635M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.76B | 1.22B | 1.53B | 1.64B | 618M | 751M | 555M | 584M | 576M | 648M | 744M | 867M | 2.04B | 191M | 755M | 895M | 1.72B | 482M | 265M | 122M | 0 | 0 | 0 | 538M | 588M | 661M | 748M | 640M | 536M | 450M | 1.66B |
| Current Ratio | 1.85x | 2.31x | 1.36x | 1.48x | 1.69x | 2.09x | 2.52x | 2.32x | 2.12x | 2.57x | 2.40x | 2.05x | 1.68x | 1.94x | 1.95x | 1.78x | 1.98x | 1.85x | 1.97x | 1.98x | 1.93x | 1.23x | 1.40x | 1.41x | 1.34x | 1.21x | 1.08x | 1.41x | 1.52x | 1.51x | 1.42x |
| Quick Ratio | 1.23x | 1.56x | 1.05x | 1.18x | 1.12x | 1.52x | 1.95x | 1.81x | 1.53x | 2.05x | 1.87x | 1.77x | 1.42x | 1.28x | 1.36x | 1.24x | 1.39x | 1.28x | 1.32x | 1.37x | 1.36x | 0.77x | 0.91x | 0.86x | 0.89x | 0.80x | 0.74x | 1.00x | 1.10x | 1.04x | 1.06x |
| Cash Conversion Cycle | 119.69 | 119.94 | 118.52 | 123.38 | 183.19 | 140.85 | 109.91 | 102.99 | 99.02 | 94.99 | 99.3 | 119.06 | 117.67 | 279.42 | 172.82 | 161.29 | 150.57 | 172.69 | 148.46 | 155.51 | 141.51 | -18 | -36.53 | 4.52 | -26.99 | 139.06 | 0.74 | 16.29 | 0.61 | 13.47 | 159.36 |
| Total Non-Current Liabilities | 10.14B | 10.98B | 12.25B | 13.3B | 17.65B | 20.16B | 7.96B | 7.05B | 5.04B | 5.17B | 4.52B | 6.35B | 11.95B | 11.49B | 8.65B | 7.39B | 6.65B | 5.47B | 5.54B | 4.57B | 4.8B | 4.26B | 6.16B | 6.63B | 5.69B | 3.29B | 2.7B | 3.6B | 4.2B | 3.53B | 2.65B |
| Long-Term Debt | 8.85B | 9.68B | 10.37B | 11.09B | 15.23B | 17.15B | 5.79B | 4.81B | 3.48B | 3.51B | 2.78B | 3.92B | 7.33B | 8.13B | 5.58B | 4.75B | 4.36B | 3.44B | 3.36B | 2.66B | 2.57B | 2.41B | 3.93B | 4.42B | 4.4B | 2.49B | 1.73B | 2.6B | 3.1B | 2.63B | 1.7B |
| Capital Lease Obligations | 679M | 244M | 243M | 265M | 447M | 522M | 501M | 510M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29M | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 245M | 245M | 103M | 403M | 661M | 962M | 143M | 192M | 215M | 280M | 93M | 195M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 218M | 160M | 311M | 461M | 316M | 255M |
| Other Non-Current Liabilities | 1.29B | 783M | 1.49B | 1.51B | 1.27B | 1.45B | 1.5B | 1.49B | 1.34B | 1.39B | 1.65B | 2.23B | 4.61B | 3.36B | 3.07B | 2.64B | 2.29B | 2.03B | 2.18B | 1.9B | 2.24B | 1.85B | 2.22B | 2.21B | 1.26B | 588M | 816M | 684M | 646M | 580M | 697M |
| Total Liabilities | 13.83B | 13.95B | 18.76B | 19.81B | 22.39B | 24.4B | 11.29B | 10.28B | 7.85B | 8B | 7.27B | 12.1B | 17.98B | 16.74B | 13.41B | 12.24B | 10.69B | 9.93B | 9.18B | 8.38B | 8.41B | 8.43B | 10.44B | 10.43B | 9.54B | 6.59B | 6.07B | 6.3B | 7.03B | 6.09B | 5.09B |
| Total Debt | 9.69B | 10B | 13.45B | 14.11B | 17.2B | 18.31B | 6.8B | 5.96B | 3.48B | 3.51B | 2.78B | 6.51B | 9.03B | 9.17B | 5.93B | 5.2B | 4.39B | 4.15B | 3.76B | 3.09B | 2.8B | 3.34B | 4.29B | 4.57B | 4.65B | 2.69B | 2.36B | 2.86B | 3.37B | 2.78B | 2.04B |
| Net Debt | 7.67B | 8.04B | 11.69B | 11.04B | 15.48B | 15.36B | 3.07B | 2.63B | 1.65B | 118M | -19M | 4.29B | 6.1B | 6.43B | 2.66B | 2.29B | 1.7B | 1.36B | 1.63B | 550M | 316M | 2.5B | 3.19B | 3.65B | 3.48B | 2.1B | 1.78B | 2.25B | 2.66B | 2.31B | 1.28B |
| Debt / Equity | 1.61x | 1.64x | 1.91x | 1.67x | 2.92x | 2.01x | 0.78x | 0.75x | 0.44x | 0.39x | 0.34x | 0.73x | 1.11x | 1.08x | 0.85x | 0.76x | 0.65x | 0.56x | 0.60x | 0.45x | 0.45x | 0.78x | 1.16x | 1.40x | 1.58x | 0.72x | 0.89x | 0.85x | 1.19x | 1.06x | 0.82x |
| Debt / EBITDA | 14.44x | 14.86x | 13.30x | 8.35x | - | 8.26x | 2.79x | 2.33x | 1.48x | 1.72x | 1.80x | 5.39x | 6.24x | 8.10x | 1.68x | 1.44x | 1.56x | 1.18x | 1.18x | 1.12x | 1.16x | 1.50x | 2.87x | 2.54x | 2.36x | 1.63x | 1.65x | 1.88x | 2.48x | 2.31x | 1.62x |
| Net Debt / EBITDA | 11.43x | 11.94x | 11.56x | 6.53x | - | 6.93x | 1.26x | 1.03x | 0.70x | 0.06x | -0.01x | 3.55x | 4.22x | 5.69x | 0.75x | 0.63x | 0.60x | 0.39x | 0.51x | 0.20x | 0.13x | 1.13x | 2.13x | 2.02x | 1.77x | 1.28x | 1.25x | 1.48x | 1.96x | 1.92x | 1.02x |
| Interest Coverage | -0.83x | -0.74x | 0.29x | 1.48x | -6.86x | 6.39x | 9.44x | 9.74x | 18.39x | 13.94x | 56.66x | 3.93x | 3.93x | 3.42x | 26.12x | 31.53x | 17.43x | 24.37x | 17.64x | 18.05x | 18.23x | 12.97x | 14.53x | 13.87x | 24.20x | 13.92x | 10.08x | - | 5.26x | - | 4.26x |
| Total Equity | 6.02B | 6.1B | 7.02B | 8.47B | 5.89B | 9.12B | 8.73B | 7.91B | 7.87B | 9.12B | 8.28B | 8.87B | 8.16B | 8.49B | 6.98B | 6.83B | 6.8B | 7.42B | 6.23B | 6.92B | 6.27B | 4.3B | 3.71B | 3.27B | 2.94B | 3.76B | 2.66B | 3.35B | 2.84B | 2.62B | 2.5B |
| Equity Growth % | -42.39% | -13.13% | -17.05% | 43.65% | -35.37% | 4.53% | 10.29% | 0.58% | -13.71% | 10.1% | -6.6% | 8.69% | -3.89% | 21.61% | 2.2% | 0.47% | -8.41% | 19.12% | -9.93% | 10.27% | 45.89% | 16.03% | 13.16% | 11.4% | -21.77% | 41.29% | -20.58% | 17.93% | 8.4% | 4.59% | -32.4% |
| Book Value per Share | 11.68 | 11.89 | 13.77 | 16.74 | 11.70 | 17.95 | 16.88 | 15.24 | 14.41 | 16.43 | 15.03 | 16.15 | 14.91 | 15.46 | 12.55 | 11.92 | 11.44 | 12.08 | 9.78 | 10.57 | 9.56 | 6.83 | 6.00 | 5.67 | 6.33 | 6.69 | 4.49 | 5.67 | 4.91 | 4.64 | 4.54 |
| Total Shareholders' Equity | 6.04B | 6.13B | 6.96B | 8.4B | 5.83B | 9.08B | 8.69B | 7.88B | 7.84B | 9.12B | 8.29B | 8.85B | 8.12B | 8.46B | 6.94B | 6.58B | 6.57B | 7.19B | 6.23B | 6.92B | 6.27B | 4.3B | 3.71B | 3.27B | 2.94B | 3.76B | 2.66B | 3.35B | 2.84B | 2.62B | 2.5B |
| Common Stock | 683M | 683M | 683M | 683M | 683M | 683M | 683M | 683M | 683M | 683M | 683M | 683M | 683M | 683M | 683M | 683M | 683M | 683M | 683M | 683M | 683M | 648M | 648M | 649M | 627M | 609M | 298M | 294M | 291M | 0 | 0 |
| Retained Earnings | 13.69B | 13.71B | 14.93B | 16.11B | 14.05B | 17.07B | 16.33B | 15.72B | 15.07B | 14.48B | 14.2B | 9.68B | 13.23B | 11.85B | 10.89B | 9.43B | 7.92B | 7.34B | 5.79B | 4.38B | 3.27B | 2.85B | 2.26B | 2.15B | 1.69B | 1.09B | 853M | 1.42B | 990M | 1.01B | 1.02B |
| Treasury Stock | 0 | -10.87B | -11.06B | -11.23B | -11.39B | -11.49B | -11.05B | -10.76B | -9.99B | -7.98B | -8B | -7.65B | -7.99B | -7.91B | -7.59B | -6.72B | -5.66B | -4.74B | -3.9B | -2.5B | -1.43B | -1.15B | -1.51B | -1.86B | -1.33B | -328M | -349M | -269M | -210M | 0 | 0 |
| Accumulated OCI | -3.8B | -3.75B | -4.01B | -3.55B | -3.83B | -3.38B | -3.31B | -3.71B | -3.82B | -4B | -4.56B | 224M | -3.65B | -1.98B | -2.81B | -2.59B | -2.14B | -1.78B | -1.89B | -940M | -1.43B | -1.5B | -1.29B | -1.43B | -1.27B | -432M | -649M | -374M | -296M | 0 | 0 |
| Minority Interest | -27M | -27M | 60M | 66M | 62M | 44M | 37M | 30M | 22M | -8M | -10M | 19M | 36M | 23M | 40M | 243M | 229M | 229M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
High leverage and restructuring
As reported in recent financial filings, Baxter's total assets have declined from $28.3 billion in 2023Q4 to $19.8 billion by 2026Q1, reflecting a deliberate, albeit aggressive, reduction in the company's asset base as it navigates the complex divestiture of its Renal Care business.
The consistent downward trend in total assets suggests that the company is actively shedding legacy operations to streamline its portfolio. Investors should monitor whether this contraction successfully improves capital efficiency or if it merely leaves the remaining entity with a diminished competitive footprint.
Based on quarterly balance sheet data, Baxter's total debt has decreased from $14.1 billion in 2023Q4 to $9.7 billion in 2026Q1, yet the debt-to-equity ratio remains elevated at 1.61, indicating that the company's financial flexibility continues to be constrained by its prior acquisition-heavy strategy.
While the absolute debt reduction is a positive step, the persistent D/E ratio suggests that the company remains highly leveraged relative to its current equity base. This leverage profile may limit the firm's ability to pursue further strategic initiatives until the Vantive separation is fully realized and debt is further retired.
According to recent SEC filings, Baxter's current ratio has fluctuated significantly, moving from 1.48 in 2023Q4 to a peak of 2.31 in 2025Q4 before settling at 1.85 in 2026Q1, highlighting the volatility in working capital management during this period of intense organizational transformation.
The variability in the current ratio suggests that the company's short-term liquidity position is highly sensitive to the timing of restructuring-related cash outflows and inventory adjustments. This lack of stability warrants caution, as it may indicate difficulty in maintaining a predictable cash buffer for operational contingencies.
As evidenced by the provided financial statements, Baxter carries $4.9 billion in goodwill as of 2026Q1, which represents a significant portion of the company's $6.0 billion in total equity, signaling a potential vulnerability to future impairment charges if the acquired businesses underperform expectations.
The high concentration of goodwill relative to equity suggests that the balance sheet is sensitive to valuation adjustments, particularly given the ongoing portfolio transformation. Investors should consider the risk that future strategic shifts or poor performance in the Hillrom-integrated segments could necessitate non-cash write-downs that would further erode the equity base.
Quick answers to the most common questions about buying BAX stock.
As of 2025, Baxter International Inc. (BAX) had total assets of $20.05B including $6.87B in current assets.
Baxter International Inc. (BAX) carries total debt of $10.00B, offset by $1.97B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
Baxter International Inc. (BAX) has total shareholders' equity (book value) of $6.13B ($11.89 book value per share). Book value represents the net worth of the company belonging to common stock holders.
Baxter International Inc. (BAX) reported a current ratio of 2.31x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.